423 related articles for article (PubMed ID: 20008931)
1. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
Mu P; Han YC; Betel D; Yao E; Squatrito M; Ogrodowski P; de Stanchina E; D'Andrea A; Sander C; Ventura A
Genes Dev; 2009 Dec; 23(24):2806-11. PubMed ID: 20008931
[TBL] [Abstract][Full Text] [Related]
2. A microRNA polycistron as a potential human oncogene.
He L; Thomson JM; Hemann MT; Hernando-Monge E; Mu D; Goodson S; Powers S; Cordon-Cardo C; Lowe SW; Hannon GJ; Hammond SM
Nature; 2005 Jun; 435(7043):828-33. PubMed ID: 15944707
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
[TBL] [Abstract][Full Text] [Related]
4. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
5. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.
Sandhu SK; Fassan M; Volinia S; Lovat F; Balatti V; Pekarsky Y; Croce CM
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18208-13. PubMed ID: 24145403
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.
Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW
Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
[TBL] [Abstract][Full Text] [Related]
8. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.
Mihailovich M; Bremang M; Spadotto V; Musiani D; Vitale E; Varano G; Zambelli F; Mancuso FM; Cairns DA; Pavesi G; Casola S; Bonaldi T
Nat Commun; 2015 Nov; 6():8725. PubMed ID: 26555894
[TBL] [Abstract][Full Text] [Related]
9. Widespread microRNA repression by Myc contributes to tumorigenesis.
Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
[TBL] [Abstract][Full Text] [Related]
10. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
[TBL] [Abstract][Full Text] [Related]
11. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D
Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
Musilova K; Mraz M
Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
[TBL] [Abstract][Full Text] [Related]
13. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.
Lwin T; Zhao X; Cheng F; Zhang X; Huang A; Shah B; Zhang Y; Moscinski LC; Choi YS; Kozikowski AP; Bradner JE; Dalton WS; Sotomayor E; Tao J
J Clin Invest; 2013 Nov; 123(11):4612-26. PubMed ID: 24216476
[TBL] [Abstract][Full Text] [Related]
14. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.
Hezaveh K; Kloetgen A; Bernhart SH; Mahapatra KD; Lenze D; Richter J; Haake A; Bergmann AK; Brors B; Burkhardt B; Claviez A; Drexler HG; Eils R; Haas S; Hoffmann S; Karsch D; Klapper W; Kleinheinz K; Korbel J; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Leich E; Loeffler M; Mantovani-Loeffler L; López C; McHardy AC; Möller P; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schlesner M; Scholz I; Stadler PF; Stilgenbauer S; Sungalee S; Szczepanowski M; Trümper L; Weniger MA; Siebert R; Borkhardt A; Hummel M; Hoell JI;
Haematologica; 2016 Nov; 101(11):1380-1389. PubMed ID: 27390358
[TBL] [Abstract][Full Text] [Related]
15. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells.
Jung YJ; Kim JW; Park SJ; Min BY; Jang ES; Kim NY; Jeong SH; Shin CM; Lee SH; Park YS; Hwang JH; Kim N; Lee DH
J Med Virol; 2013 Jun; 85(6):969-78. PubMed ID: 23532756
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.
Inomata M; Tagawa H; Guo YM; Kameoka Y; Takahashi N; Sawada K
Blood; 2009 Jan; 113(2):396-402. PubMed ID: 18941111
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Emu-c-myc or N-myc transgenes.
Linardopoulos S; Silva S; Klein G; Balmain A
Int J Cancer; 2000 Dec; 88(6):920-7. PubMed ID: 11093815
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Biogenesis of pri-miR-17∼92 Reveals Hierarchy and Competition among Polycistronic MicroRNAs.
Donayo AO; Johnson RM; Tseng HW; Izreig S; Gariepy A; Mayya VK; Wu E; Alam R; Lussier C; Jones RG; Duchaine TF
Mol Cell; 2019 Jul; 75(2):340-356.e10. PubMed ID: 31253575
[TBL] [Abstract][Full Text] [Related]
19. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.
Tao J; Zhao X; Tao J
Cell Cycle; 2014; 13(2):191-8. PubMed ID: 24394940
[TBL] [Abstract][Full Text] [Related]
20. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
